Abstract

Personalized nanomedicine has rapidly evolved over the past decade to tailor the diagnosis and treatment of several diseases to the individual characteristics of each patient. In oncology, iron oxide nano-biomaterials (NBMs) have become a promising biomedical product in targeted drug delivery as well as in magnetic resonance imaging (MRI) as a contrast agent and magnetic hyperthermia. The combination of diagnosis and therapy in a single nano-enabled product (so-called theranostic agent) in the personalized nanomedicine has been investigated so far mostly in terms of local events, causes-effects, and mutual relationships. However, this approach could fail in capturing the overall complexity of a system, whereas systemic approaches can be used to study the organization of phenomena in terms of dynamic configurations, independent of the nature, type, or spatial and temporal scale of the elements of the system. In medicine, complex descriptions of diseases and their evolution are daily assessed in clinical settings, which can be thus considered as complex systems exhibiting self-organizing and non-linear features, to be investigated through the identification of dynamic feedback-driven behaviors. In this study, a Systems Thinking (ST) approach is proposed to represent the complexity of the theranostic modalities in the context of the personalized nanomedicine through the setting up of a stock-flow diagram. Specifically, the interconnections between the administration of magnetite NBMs for diagnosis and therapy of tumors are fully identified, emphasizing the role of the feedback loops. The presented approach has revealed its suitability for further application in the medical field. In particular, the obtained stock-flow diagram can be adapted for improving the future knowledge of complex systems in personalized nanomedicine as well as in other nanosafety areas.

Highlights

  • In the last years, the use of nano-biomaterials (NBMs) has led to great improvements in several biomedical applications such as diagnostic, therapeutic, and regenerative medicine (Wang et al, 2018)

  • Magnetite (Fe3O4) NBMs can be used as contrast agent in magnetic resonance imaging (MRI) for diagnosis purposes, while in therapeutic nanomedicine they can be accumulated in cancer cells through the enhanced permeability and retention effect (Nuzhina et al, 2019), generating heat upon the application of an alternate magnetic field (MF) in hyperthermia treatments (Vallabani and Singh, 2018)

  • We present for the first time a structural graphic model for the representation of theranostic modalities of a nanobased biomedical product

Read more

Summary

Introduction

The use of nano-biomaterials (NBMs) has led to great improvements in several biomedical applications such as diagnostic, therapeutic, and regenerative medicine (Wang et al, 2018). Magnetite (Fe3O4) NBMs can be used as contrast agent in magnetic resonance imaging (MRI) for diagnosis purposes, while in therapeutic nanomedicine they can be accumulated in cancer cells through the enhanced permeability and retention effect (Nuzhina et al, 2019), generating heat upon the application of an alternate magnetic field (MF) in hyperthermia treatments (Vallabani and Singh, 2018). The combination of therapeutic and diagnostic capabilities using a single nano-based biomedical product, the so-called nanotheranostic (Theek et al, 2014), addresses the administration of Fe3O4 NBMs to (i) obtain in vivo imaging of the tumor site, (ii) treat the tumor site after the target drug delivery, and (iii) induce cancer cell death by hyperthermia. As health systems are self-organizing and tightly linked, constantly changing and governed by positive or negative feedbacks (WHO, 2009), there is the need to identify and represent their complexity in a holistic perspective

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call